Cargando…
Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064995/ https://www.ncbi.nlm.nih.gov/pubmed/31876051 http://dx.doi.org/10.1111/pcn.12971 |
| _version_ | 1783504977062264832 |
|---|---|
| author | Higuchi, Susumu Miyata, Hisatsugu Hayashi, Takako |
| author_facet | Higuchi, Susumu Miyata, Hisatsugu Hayashi, Takako |
| author_sort | Higuchi, Susumu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7064995 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70649952020-03-16 Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’ Higuchi, Susumu Miyata, Hisatsugu Hayashi, Takako Psychiatry Clin Neurosci Letters to the Editor John Wiley & Sons Australia, Ltd 2020-01-25 2020-03 /pmc/articles/PMC7064995/ /pubmed/31876051 http://dx.doi.org/10.1111/pcn.12971 Text en © 2020 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Higuchi, Susumu Miyata, Hisatsugu Hayashi, Takako Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’ |
| title | Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’ |
| title_full | Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’ |
| title_fullStr | Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’ |
| title_full_unstemmed | Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’ |
| title_short | Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’ |
| title_sort | response to ‘nalmefene in alcohol‐dependent patients with a high drinking risk: a limited efficacy in reducing alcohol consumption’ |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064995/ https://www.ncbi.nlm.nih.gov/pubmed/31876051 http://dx.doi.org/10.1111/pcn.12971 |
| work_keys_str_mv | AT higuchisusumu responsetonalmefeneinalcoholdependentpatientswithahighdrinkingriskalimitedefficacyinreducingalcoholconsumption AT miyatahisatsugu responsetonalmefeneinalcoholdependentpatientswithahighdrinkingriskalimitedefficacyinreducingalcoholconsumption AT hayashitakako responsetonalmefeneinalcoholdependentpatientswithahighdrinkingriskalimitedefficacyinreducingalcoholconsumption |